The US Food and Drug Administration (FDA) is committed to helping facilitate American patients’ access to lower-cost generic medicines by taking steps to enhance and streamline the development and ...

The US FDA Commissioner Scott Gottlieb announced new steps aimed at speeding up the process of reviewing generic drug marketing application and boosting competition. In a statement, the FDA regulator ...

TAIPEI (Taiwan News) — Taiwan is intensifying efforts in generic drug development to strengthen the global competitiveness of its pharmaceutical industry, with 11 local firms currently participating ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

The government has initiated a sweeping overhaul of the drug pricing system to lower the prices of generic drugs, which have been criticized for being more expensive than international standards. The ...

Viatris Inc. (NASDAQ:VTRS), a prominent player in the biopharmaceutical industry with a market capitalization of $9.73 billion, finds itself navigating a complex landscape of challenges and ...